First-Line Antibiotic for Pediatric Acute Bacterial Sinusitis
For most children ≥2 years old with uncomplicated, mild-to-moderate acute bacterial sinusitis, amoxicillin at 45 mg/kg/day divided twice daily is the first-line antibiotic. 1
Risk-Stratified Antibiotic Selection
The choice between amoxicillin alone versus amoxicillin-clavulanate depends on specific risk factors:
Standard-Dose Amoxicillin (45 mg/kg/day in 2 divided doses)
Use for children who meet ALL of the following criteria 1:
- Age ≥2 years
- Mild to moderate severity
- No daycare attendance
- No antibiotics in past 4 weeks
- Community prevalence of nonsusceptible S. pneumoniae <10%
High-Dose Amoxicillin (80-90 mg/kg/day in 2 divided doses, max 2g/dose)
Use when 1:
- Community prevalence of nonsusceptible S. pneumoniae >10%
- Otherwise meets standard-dose criteria above
High-Dose Amoxicillin-Clavulanate (80-90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day clavulanate in 2 divided doses)
Required for children with ANY of these risk factors 1:
- Age <2 years
- Moderate to severe illness at presentation
- Daycare attendance
- Recent antibiotic use (within past 30 days)
Important caveat: The 2012 IDSA guideline recommends amoxicillin-clavulanate over amoxicillin alone as first-line for all children with acute bacterial sinusitis 2. However, the 2013 AAP guideline provides more nuanced, risk-stratified recommendations that allow amoxicillin alone for low-risk children, which is more practical and reduces unnecessary clavulanate exposure 1.
Rationale for Amoxicillin
Amoxicillin remains first-line based on 1:
- Proven effectiveness against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
- Excellent safety profile
- Acceptable taste for children
- Low cost
- Narrow microbiologic spectrum (reduces collateral damage to normal flora)
Alternative for Special Circumstances
Ceftriaxone 50 mg/kg IM/IV (single dose) 1:
- For children who are vomiting
- Unable to tolerate oral medication
- Unlikely to be adherent initially
- Provides 95-100% coverage of the three major pathogens
- Switch to oral antibiotics after 24 hours if improved
Treatment Duration
10-14 days is recommended for children 2, or continue for 7 days after symptom resolution (minimum 10 days total) 1.
Common Pitfalls to Avoid
- Don't prescribe antibiotics for viral rhinosinusitis: Only treat when strict clinical criteria are met (persistent symptoms >10 days without improvement, severe symptoms with high fever ≥102°F and purulent discharge for ≥3 consecutive days, or worsening symptoms after initial improvement) 1
- Don't underdose: High-dose therapy is critical for overcoming resistance in at-risk populations
- Don't use amoxicillin alone in high-risk children: β-lactamase-producing H. influenzae (10-42% prevalence) and M. catarrhalis (nearly 100%) will not respond 1
- Don't routinely cover for MRSA: Not indicated for initial empiric therapy despite being a potential pathogen 2